NNovo Nordisk Read More Novo Relaunches Diabetes Pill as Ozempic, Hopes to Compete with Eli Lilly, ETManufacturing2026-05-02 Novo Nordisk is relaunching a diabetes tablet as Ozempic in the United States.Novo Nordisk A/S is rebranding an…
NNovo Nordisk Read More Novo rebrands diabetes pill as Ozempic to tap blockbuster name2026-05-01 Novo Nordisk A/S is rebranding an existing, less-popular diabetes tablet as Ozempic in the US in a bid…
NNovo Nordisk Read More Novo Nordisk to showcase Wegovy data at obesity meet2026-04-30 Key Summary Novo Nordisk to unveil major obesity research at the European Congress, including new Wegovy data. Next-gen…
NNovo Nordisk Read More Novo Nordisk Expands GLP-1 Reach With Pediatric Oral Semaglutide Data2026-04-24 Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
NNovo Nordisk Read More Novo Nordisk’s oral semaglutide demonstrates potential to be the first oral GLP-1 RA therapy for children and adolescents with type 2 diabetes2026-04-23 PIONEER TEENS is the first clinical trial of an oral GLP-1 RA therapy in children and adolescents aged…
NNovo Nordisk Read More Novo Nordisk’s pill could be first oral GLP-1 RA therapy for children and adolescents with T2D2026-04-23 Novo Nordisk today announced positive topline results from a Phase III trial evaluating oral semaglutide for type 2…
NNovo Nordisk Read More Novo Nordisk withstands stiff generic competition post semaglutide patent expiry in India in March, 26 brands from 13 firms launched2026-04-16 Danish drug major Novo Nordisk seems to be withstanding stiff competition from generic players after its global blockbuster…
NNovo Nordisk Read More India’s GLP-1 Market Heats Up: Novo Nordisk Faces Generics2026-04-16 Novo Nordisk’s globally recognized diabetes and weight-loss drug, semaglutide, has entered a new competitive phase in India following…
NNovo Nordisk Read More Eli Lilly’s Mounjaro loses ground to Novo Nordisk’s semaglutide, and the slew of cheaper generics2026-04-09 A Mounjaro injection used for weight loss procedures at a clinic in Mumbai, March 31, 2026. | Photo…
NNovo Nordisk Read More Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakers2026-04-09 A surge of low-cost copies of Novo Nordisk’s blockbuster drug semaglutide in India is rapidly reshaping the country’s…
NNovo Nordisk Read More Novo Nordisk’s Wegovy® HD available now nationwide2026-04-07 Wegovy® HD available through 70,000+ US pharmacies, NovoCare® Pharmacy, select telehealth providers, and more Wegovy® HD further expands the offerings…
NNovo Nordisk Read More Novo Nordisk slashes Ozempic, Wegovy prices as generic competition heats up2026-03-31 Mumbai: Innovator Novo Nordisk on Tuesday said it is reducing the starting dose prices for its semaglutide brands…